Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.


Journal

The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 22 7 2020
medline: 17 8 2021
entrez: 22 7 2020
Statut: ppublish

Résumé

The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and potentially increase patients' inflammatory response. These complications could be reduced by the use of locking solutions. To analyse biofilm formation, using confocal and electron microscopy, in tunnelled cuffed catheters locked with three different solutions and to determine the relationship between these solutions and inflammatory response. This prospective study included 35 haemodialysis patients with tunnelled cuffed catheter removal for non-infection-related reasons. The participants were divided into three groups according to the lock solution used: (1) heparin 1: 5000 IU; (2) citrate 4%; and (3) taurolidine 1.35%, citrate 4% and heparin 500 IU (taurolock); in the latter group, 25,000 IU taurolidine-urokinase was used in the last weekly session. All tunnelled cuffed catheters were cultured, and the inner surface was evaluated with confocal and electron microscopy. The inflammatory profile of included patients was determined at tunnelled cuffed catheter removal. There were no differences in clinical or demographic variables between the three subgroups. Biofilm thickness was lower in the taurolidine group than in the citrate 4% and heparin groups (28.85 ± 6.86 vs 49.99 ± 16.56 vs 56.2 ± 15.67 µm, respectively; Our results show that biofilms were found in all tunnelled cuffed catheters, but the thickness and volume were significantly lower in tunnelled cuffed catheters locked with taurolidine solution. Therefore, the type of locking solution used in tunnelled cuffed catheters should maintain tunnelled cuffed catheter sterility and prevent catheter-related bloodstream infections. No significant difference was observed in the inflammatory profile according to the type of locking solution.

Identifiants

pubmed: 32691665
doi: 10.1177/1129729820942040
doi:

Substances chimiques

Anti-Infective Agents 0
Anticoagulants 0
IL6 protein, human 0
Inflammation Mediators 0
Interleukin-6 0
Thiadiazines 0
Taurine 1EQV5MLY3D
Citric Acid 2968PHW8QP
taurolidine 8OBZ1M4V3V
Heparin 9005-49-6

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

370-379

Auteurs

Mario Jiménez Hernández (M)

Department of Nephrology, Hospital Clínic de Barcelona, Barcelona, Spain.
School of Medicine, Universidad de las Americas Puebla, San Andrés Cholula, Puebla, Mexico.

Alex Soriano (A)

Department of Infectious Diseases, Hospital Clínic de Barcelona, Barcelona, Spain.

Xavier Filella (X)

Biomedical Diagnostic Center, Hospital Clínic de Barcelona, Barcelona, Spain.

María Calvo (M)

Advanced Optical Microscopy Unit, Scientific and Technological Centers of the University of Barcelona, Barcelona, Spain.

Elisenda Coll (E)

Advanced Optical Microscopy Unit, Scientific and Technological Centers of the University of Barcelona, Barcelona, Spain.

Josep M Rebled (JM)

Unitat de Microscòpia Electrònica (TEM/SEM), Centres Científics i Tecnològics, Barcelona, Spain.

Esteban Poch (E)

Department of Nephrology, Hospital Clínic de Barcelona, Barcelona, Spain.

Fredzia Graterol (F)

Department of Nephrology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

María Teresa Compte (MT)

Hospital de la Santa Creu de Jesus, Tortosa, Spain.

Francisco Maduell (F)

Department of Nephrology, Hospital Clínic de Barcelona, Barcelona, Spain.

Néstor Fontsere (N)

Department of Nephrology, Hospital Clínic de Barcelona, Barcelona, Spain.
Vascular Access Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH